Black Diamond Therapeutics, Inc.
BDTX
$2.02
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.21% | -115.98% | 5.44% | 45.38% | 46.95% |
| Total Depreciation and Amortization | -67.44% | -68.97% | -22.35% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.84% | -10.29% | 456.95% | 33.79% | -56.54% |
| Change in Net Operating Assets | 102.24% | 41.94% | -21.08% | -167.65% | -470.97% |
| Cash from Operations | 13.00% | -119.16% | 54.92% | 30.67% | 37.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -62.50% | -97.92% | -73.68% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.72% | 128.50% | -110.42% | 300.42% | -8,527.78% |
| Cash from Investing | 94.72% | 128.15% | -110.40% | 291.70% | -8,093.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 287.07% | -678.13% | -167.35% | 153.17% | -100.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.11% | -85.35% | -175.91% | 109.32% | -1,025.70% |